Menu
Search
|

Menu

Close
X

Eli Lilly and Co LLY.N (New York Stock Exchange)

85.92 USD
-- (--)
As of Jun 22
chart
Previous Close 85.92
Open --
Volume --
3m Avg Volume 1,231,363
Today’s High --
Today’s Low --
52 Week High 89.07
52 Week Low 73.70
Shares Outstanding (mil) 1,085.43
Market Capitalization (mil) 93,260.18
Forward P/E 29.77
Dividend (Yield %) 0.56 ( 2.62 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.20 Mean rating from 20 analysts

KEY STATS

Revenue (mm, USD)
FY18
5,700
FY17
22,871
FY16
21,222
FY15
19,959
EPS (USD)
FY18
1.160
FY17
1.621
FY16
2.578
FY15
2.261
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
29.77
34.14
Price to Sales (TTM)
vs sector
4.00
8.17
Price to Book (MRQ)
vs sector
6.42
4.30
Price to Cash Flow (TTM)
vs sector
20.09
22.70
Total Debt to Equity (MRQ)
vs sector
80.52
17.55
LT Debt to Equity (MRQ)
vs sector
64.66
13.12
Return on Investment (TTM)
vs sector
10.15
13.10
Return on Equity (TTM)
vs sector
21.28
15.09

EXECUTIVE LEADERSHIP

David Ricks
Chairman of the Board, President, Chief Executive Officer, Since 2017
Salary: $1,400,000.00
Bonus: $2,814,000.00
Joshua Smiley
Chief Financial Officer, Senior Vice President, Since 2018
Salary: --
Bonus: --
Jan Lundberg
Executive Vice President - Science and Technology, President - Lilly Research Laboratories, Since 2010
Salary: $1,024,640.00
Bonus: $1,373,020.00
Aarti Shah
Senior Vice President - Information Technology, and Chief Information Officer, Since 2018
Salary: --
Bonus: --
Melissa Barnes
Senior Vice President - Enterprise Risk Management and Chief Ethics and Compliance Officer, Since 2013
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

Lilly Corporate Ctr, Drop Code 1
INDIANAPOLIS   IN   46285

Phone: +1317.2762000

Eli Lilly and Company is engaged in drug manufacturing business. The Company discovers, develops, manufactures and markets products in two segments: human pharmaceutical products and animal health products. The Company's human pharmaceutical business segment sells medicines, which are discovered or developed by its scientists. Its animal health business segment operates through the Company's Elanco division, which develops, manufactures and markets products for both food animals and companion animals. The Company's human pharmaceutical products include endocrinology products, neuroscience products, oncology products, immunology products and cardiovascular products. The Company's animal health products segment includes products for food animals and products for companion animals. As of December 31, 2016, the Company manufactured and distributed its products through facilities in the United States, Puerto Rico and 14 other countries.

SPONSORED STORIES